Notice of Interim Results

Cathay International Holdings Limited

("Cathay" or the "Company")

Notice of Interim Results

Hong Kong, 15 August 2011 - Cathay International Holdings Limited (LSE: CTI.L), an investment holding company and a leading investor in the growing healthcare sector in the People's Republic of China, today announces that it will issue its Interim Results for the six months ended 30 June 2011 at 1700hrs (BST) on Thursday, 25 August 2011.

-Ends-

For further enquiries, please contact:

About Cathay International Holdings Limited

Cathay International Holdings Limited ("CIH"), focused on the People's Republic of China ("PRC"), is an investment holding company and a leading investor in the growing healthcare sector in China. The Group now employs more than 1700 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's headquarters in Hong Kong and Shenzhen.

The Group aims to identify investment opportunities with emphasis on high growth healthcare markets and build them into market sector leaders, with a clear exit strategy. The Group has demonstrated a strong track record of identifying potential high-growth investment opportunities in this area, including: Lansen Pharmaceutical Holdings Limited, a leading specialty pharmaceutical company focused on rheumatology and Haotian Holdings Limited, a company engaged in the manufacture, marketing and sale of key active ingredients for healthcare products, including inositol. To complement its healthcare portfolio, CIH has an R&D business focused on bringing new products to the growing Chinese market.

The Group also has a private equity investment arm focused on minority investment opportunities and a hotel investment.

The Company's website is at http://www.cathay-intl.com.hk.